Glaxo Smith Kline (BIOC)

• Stock
• Company Profile
• News
• Announcements
• Fair Values
• Corporate Actions
• Earning Announcements
• News Reports
• Insider Trades
• Volume Statistics
• Financial Ratios
• IPOs
• Financial Statements
• Support and resistance
• More

{{ 'components.chart.period.' + period | translate }}

{{ 'components.chart.type.' + type | translate }}

This mark means that there are news on this date.

Stock

Par Value 10.0 Egyptian Pound

Market Cap 5,609,648,814.00 Egyptian Pound

Book Value (BVPS) 23.89 Egyptian Pound Based on: Fourth Quarter 2024

P/B Ratio 1.56 Last update: 2025-07-01

EPS 3.26 Egyptian Pound Based on: Fourth Quarter 2024

P/E Ratio 56.63 Last update: 2025-07-01

Trading Currency Egyptian Pound

Company Statistics

News

GSK Egypt posts lower consolidated net profits at EGP 30m in 9M-25 Financial Results

GSK Egypt’s consolidated net profits shrink to EGP 65m in H1-25 Financial Results

GSK Egypt posts EGP 106m consolidated profits in 9M-24 Financial Results

GSK Egypt’s net profits hike in H1-24 Financial Results

GSK Egypt turns to loss in Q1-24 Financial Results

GSK Egypt obtains shareholders’ nod for 2023 cash dividends Cash Dividends

Market Announcements